Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap

Completed · Not applicable

Conditions studied: End Stage Renal Disease (ESRD)

In brief

To assess positive blood cultures (PBCs) in hemodialysis central venous catheter (CVC) patients using two FDA cleared devices: ClearGuard HD end caps compared to conventional end caps.

Key facts

Study ID

NCT02604264

Run by

Pursuit Vascular, Inc.

People needed

2912

Starts

2014-12-01

Expected to finish

2015-11-01

Last updated by the study team

2018-09-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients dialyzing with a central venous catheter

You may not qualify if…

• Known allergy to chlorhexidine

Where it is running

• Frenova Renal Research — Waltham, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.